Skip to search formSkip to main contentSkip to account menu

levomilnacipran

Known as: (1S,2R)-milnacipran 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
In the past six years, FDA has approved the three new Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin Norepinephrine… 
Review
2015
Review
2015
[ILLUSTRATION OMITTED] How do they work? What makes them different? And which patients might benefit most from taking them? With… 
2015
2015
Seven topics previously described in this column are revisited. The use of quantitative electroencephalography has been shown in… 
2014
2014
Objective: Levomilnacipran ER is a potent and selective serotonin and norepinephrine reuptake inhibitor (SNRI) approved for the… 
2013
2013
  • 2013
  • Corpus ID: 20735790
NEW DRUGS Fetzima for Major Depression The FDA has approved levomilnacipran extended-release capsules (Fetzima, Forest/Pierre… 
Review
2012
Review
2012
A review of drug therapies and research presented at the 2012 Annual Meeting of the American Psychiatric Association 
2012
2012
In humans, levomilnacipran was the major circulating compound after dosing (Image 1) accounting for 52.9% of the total… 
2011
2011
La presente invention concerne des formes posologiques stables de levomilnacipran et de sels pharmaceutiquement acceptables de…